Having confirmed the direct binding of STAT3 and STAT6 to the Bcl‐XL promoter in HEK293T cells, we next aimed to test the DNA‐binding capacity of STAT3 and STAT6 in primary CLL cells. The gene discussed is STAT6; the disease is B-cell chronic lymphocytic leukemia.